The Measles Market is projected to reach USD 3.41 Billion by 2032 at 7.9% CAGR during the forecast period 2023-2032. Measles or rubeolais known to be a highly contagious disease. This disease is also caused by the virus of rubeola. If an individual is already infected with the measles or rubeola virus, then there is more possibility to spread it to other contacted person. The measles disease has specific early symptoms that include cough, running nose, red eyes, and fever. Also, the infected person can face tiny rashes and red spots on the skin. A virus that spreads measles belongs to the genus Morbillivirus and the paramyxovirus family.
The measles first infects the respiratory tract, which further spreads to the whole body. This disease is basically seen predominantly among children. In the past decades, its spread has been uncontrollable, but now the disease is in control to a large extent. However, still, measles is a matter of concern for the healthcare sector across the globe. Thus, vaccinations are provided to children in many developed nations by the age of 18 months to immunize their bodies from the diseases. The vaccination for measles is not recommended after the completion of the 18 months to the child as they already received the adequate quantity of immunoglobulin through the placenta.
According to the Measles Market Outlook report, the worldwide market has involved different intended audiences, including pharmaceutical companies, academic institutes and universities, biotechnological industries, hospitals and clinics, and research and development (R&D) companies. This market intended audiences are contributing majorly to the global market by supporting its growth.
COVID-19 Analysis
The Measles Market Growth has been affected negatively due to the covid-19 outbreak. The coronavirus has enforced every country's government to take some action like lockdown and shutdown. This has resulted in effecting disruption in the manufacturing chain and supply chain. Even people were unable to take vaccination at the right time as it was postponed for a certain period of time.
However, the market players of the Market have acted an important role in propelling its performance in the forecast period. Presently, it is predicted to access everything and achieve the goal by the forecast period.
The rising number of patients with immunosuppressant diseases and rising population with measles is projected to drive the measles market during the forecast period.
The World Health Organization (WHO) report of 1980 states that nearly 2.6 million deaths have been estimated every year due to measles in the research period. Moreover, the 2015 report states that nearly 134000 people died because of measles across the world. In the same year, the dose of the measles vaccinewas given to 85% of the children across the world. However, the rising requirements for better treatment,growing prevalence of autoimmune diseases, growing support of government for research & development, andrapid developments in technology are some of the major growth driving factors for the market.
The worldwide Measles Market might experience challenges due to the high cost associated with the measles treatment.
Moreover, the covid-19 pandemic has disrupted the Market’s manufacturing chain and supply chain, which is one of the biggest challenges for the global market.
The measles disease is widely infected theimmunosuppressant diseases patients. Thus, the drug treatment is highly administered during the initial stages. Additionally, the diseases can be prevented with one of the most efficient ways, that is vaccination. These kinds of initiatives are bringing more growth opportunities for the measles market.
Moreover, the increasing research and developmental initiatives and new product launches among the key players are projected to bring lucrative opportunities for the market during the assessment period.
The measles market Size might get affected because of the high cost associated with the treatments of measles.
Moreover, the limited availability of the treatment for measles can hamper the growth of the market during the review period.
Cumulative Evaluation of The Market
In the past few years, the measles market Value has increased significantly and is further estimated to maintain the flow to enhance the market performance in the upcoming years.
However, the availability of treatments for the measles-like antiviral treatment, antibiotic treatment, vaccine, and others are predicted to enhance the performance of the market in the further coming years.
As per the Measles Market Trends report, the global market has been classified in terms of end-users, treatment, and types.
Depending on the end-user segment, the market has been segregated into clinics, hospitals, and others.
In terms of the treatment segment, the worldwide market has been classified into antiviral treatment, antibiotic treatment, vaccine and others.
Further, the vaccines segment is sub-classified into live (MMR-II) & mumps measles-rubella, mumps measles-rubella vaccine, and varicella virus vaccine (Proquad). In 2016, the vaccines segment was projected to generate the largest Measles Market Share during the review period. On the other hand, antibiotic treatment is registered to generate 25% of the market share in the research period.
Based on the type segment, the present market has been divided into German measles and red measles.
The measles market has been categorized based on the application, such as adults and children.
Regionally, the Measles Markethas been categorized into Europe, North America, Asia-Pacific, South America and the Rest of the World (RoW).
Globally, the American measles market is registered to lead the market during the review period because of the rising patient population with measles and well-developed technology in the region. In the United States, the number of cases of measles has reduced significantly due to the vaccination. However, the rising vaccine refusals in recent years are occurring the measles in the US. In addition, the regional market growth depends on the presence of some of the leading players, high healthcare expenditure and rising prevalence of immunological diseases in the region.
Furthermore, the European measles market is considered to be the second-largest market during the assessment period. This regional market is expanding due to theavailability of funds for research and developmental activities and the rising support of the government. Additionally, the Asia pacific regional market for measles is predicted to be the fastest-growing market across the world during the research period because of the rapidly developing medical sector and rising population base in the region. Moreover, the Middle East & African regional market is expected to generate the least market share during the forecast timeframe due to the poor economic and political conditions and limited availability of medical facilities in the region.
Competitive Intensity Within the Industry
The measles marketperformance is getting fuelled due to the continuous efforts of the prominent market players, which includes:
According to the Measles Market Analysisreport, these prominent market players are focusing on launching new products, mergers and acquisitions, and partnerships to boost global market growth. Moreover, they are investing in research and development relating to measles, which is enhancing the market growth in the forecast period.
Recent Market Developments
Report Overview
As per the Measles Market Forecast report, a detailed analysis of the market for measles has been taken by implementing both qualitative and quantitative methods. This report has covered the market segments like types, applications, treatments and end-users that have an important role in the global market.
Further, this report has thrown light on the covid-19 analysis, market overview, market dynamics, regional analysis, competitive analysis, and recent developments. The report states that significant growth is projected in the Measles Market for the upcoming years.
| Report Attribute/Metric | Details |
| Market Size | USD 3.41 Billion |
| CAGR | 7.9% |
| Base Year | 2021 |
| Forecast Period | 2023-2032 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Types, Treatment, and End Users |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Abbott (US), Novartis AG (Switzerland), Biomedical diagnostics (US), Johnson & Johnson Services, Inc. (US), Sanofi (US), Merck & Co., Inc. (US), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), MedImmune (US Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (US), and GlaxoSmithKline plc (US), and others. |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers | · Increasing number of people with measles · Increasing patients with immunosuppressant diseases |
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
